Previous close | 26.71 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | N/A |
Market cap | N/A |
Beta (5Y monthly) | 1.01 |
PE ratio (TTM) | N/A |
EPS (TTM) | -19.21 |
Earnings date | 10 May 2023 - 15 May 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Viridian Therapeutics ( NASDAQ:VRDN ) Third Quarter 2022 Results Key Financial Results Net loss: US$28.9m (loss widened...
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...